Analysis of percutaneous coronary interventions in a 10-year period (2005–2015) – a single center experience

Authors

  • Ana Reschner 1. Zdravstveni zavod Reschner, Smoletova 18, 1000 Ljubljana 2. Mednarodni center Medicor, Polje 35, Polje 35, 6310 Izola
  • Maja Rojko Mednarodni center Medicor, Polje 35, Polje 35, 6310 Izola
  • Hrvoje Reschner 1. Zdravstveni zavod Reschner, Smoletova 18, 1000 Ljubljana 2. Mednarodni center Medicor, Polje 35, Polje 35, 6310 Izola
  • Igor Zupan 1. Mednarodni center Medicor, Polje 35, Polje 35, 6310 Izola 2. Klinični oddelek za kardiologijo, Univerzitetni klinični center, Zaloška 7, 1000 Ljubljana
  • Andrej Cijan Zdravstveni zavod Reschner, Smoletova 18, 1000 Ljubljana
  • Metka Zorc Mednarodni center Medicor, Polje 35, Polje 35, 6310 Izola
  • Marko Noč 1. Mednarodni center Medicor, Polje 35, Polje 35, 6310 Izola2. Klinični oddelek za intenzivno interno medicino, Univerzitetni klinični center, Zaloška 7, 1000 Ljubljana

DOI:

https://doi.org/10.6016/ZdravVestn.2253

Keywords:

percutaneous coronary intervention, unprotected left main

Abstract

Background: Medicor was established as the third cardiovascular center in Slovenia and started with percutaneous cardiovascular interventions in 2005. The purpose of our study was to describe the features and results of percutaneous coronary intervention (PCI) performed between 2005 and 2015.

Methods: Our retrospective descriptive study included consecutive patients undergoing PCI, who were enrolled in the PCI Registry. Patient characteristics, coronary anatomy, PCI features, use of coronary stents, procedural success and complications were investigated. Special emphasis was put on patients undergoing unprotected left main PCI.

Results: During the study period, 1981 PCI procedures were performed. PCI patients were mainly men (73 %), their average age was 65+10 years and a majority (94 %) had stable coronary disease with mutivessel involvement (62 %). PCI was performed on 2978 lesions (1.50 lesion/patient) with an average diameter stenosis of 85+10 %. Target lesion was located either in the left anterior descending artery (42.9 %), right coronary artery (32.4 %), left circumflex artery (18.4 %), left main (3 %), surgical grafs (2.3 %) or in the intermediate artery (1 %). Balloon angioplasty alone was used in 9.6 % while other patients received 1 to 7 stents (1.44+0.86 per patient). Until 2009, drug eluting stents (DES) penetration ranged between 20 % and 30 %. It then increased to 80 % in 2012 and 100 % in 2015. PCI was angiographically successful in 95.2 %. Because of PCI complications, 4 patients (0.2 %) required immediate open-heart surgery and 4 patients (0.2 %) a surgical intervention at the femoral access site. Hospital mortality was 0 %. Stent thrombosis within 30 days was documented in 6 patients (0.3 %). In a subgroup of 58 patients undergoing unprotected lef main PCI, provisional stenting was used in 88 %. DES penetration was 94 %. PCI was angiografcally successful in all patients. Hospital and 30-day mortality rates were 0 %, 1-year mortality 1.7 % (95 % confidence interval 0–11 %) and 5-year mortality 13.8 % (95 % confidence interval 7–33 %). Target vessel revascularization at 5 years was 3.5 % (95 % confidence interval 0–23 %).

Conclusion: PCI in patients with predominantly stable coronary artery disease in the Medicor Cardiovascular Center appears to be an effective and safe method of revascularization, which is also true for an intervention in unprotected left main.

Downloads

Download data is not yet available.

References

Černič Šuligoj N, Zorc M, Grad A, Kar S, Noč M. Perkutano zapiranje ovalnega okna-izkušnje z novejšimi tipi zapiral. Slov Kardiol. 2011;8(1/2):13–17.

Noč M, Cernič Šuligoj N, Zvan B, Zorc M, Kar. In-tunnel closure of patent foramen ovale with FlatStent EFTM. Polish Heart J. 2015;73(6):419–423.

Čenič Šuligoj N, Zorc M, Kar S, Noč M. Perkutano zapiranje defekta medpreddvornega septuma tipa secundum pri odraslih bolnikih-naše izkušnje. Slov Kardiol. 2012;9(1):4–9.

Černič Šuligoj N, Zorc M, Kar S, Noč M. Alkoholna septalna ablacija pri hipertrofčni obstruktivni kardiomiopatiji-naše izkušnje. Slov Kardiol. 2013;10(1):8–13.

Šuligoj B, Černič-Šuligoj N, Zorc M, Noč M, Kar S. Retrograde transcatheter closure of ventricular septal defect with Amplatzer Ductal Occluder ll. Adv Interv Cardiol. 2016;12(2):1–2.

Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Toracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–619.

De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med. 2014;371(15):1208–17.

Morice MC, Serruys PW, Kappetein P, Feldman TE, Stahle E, Colombo A, et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with Taxus and cardiac surgery trial. Circulation. 2014;129(23):2388–94.

Ahn JM, Roh JH, Kim YH, Park DW, Yun SC, Lee PH, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT study. J Am Coll Cardiol. 2015;65(20):2198–206.

Makikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected lef main stenosis (NOBLE): a prospective, randomized, open-label, non-inferiority trial. Lancet. 2016;388(10061):2743–52.

Stone GW, Sabik JF, Serruys PW, Simonton CA, Genereux P, Puskas J, et al. Everolimus-eluting sten tor bypass surgery for left main coronary artery disease. N Engl J Med. 2016;375(23):2223–235.

Downloads

Published

2017-04-15

Issue

Vol. 86 No. 3-4 (2017): March-April

Section

Original article

License


The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.

The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory

The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.

The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.

The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence. 

How to Cite

1.
Analysis of percutaneous coronary interventions in a 10-year period (2005–2015) – a single center experience. ZdravVestn [Internet]. 2017 Apr. 15 [cited 2024 Nov. 2];86(3-4):95-104. Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/2253

Most read articles by the same author(s)

1 2 > >>